Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitor - Wikidata - awgldk - TriplyDB

Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitor

Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitor

http://www.wikidata.org/entity/Q35091549

about

Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa In vitro antiplasmodial activity of crude extracts of Tetrapleura tetraptera and Copaifera religiosa In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin Icacina senegalensis (Icacinaceae), traditionally used for the treatment of malaria, inhibits in vitro Plasmodium falciparum growth without host cell toxicity.Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay.Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry.Monitoring PfMDR1 transport in Plasmodium falciparum.Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.Shelf life of predosed plates containing mefloquine, artemisinin, dihydroartemisinin, and artesunate as used for in vitro Plasmodium falciparum susceptibility assessment Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates.Geometric least squares means ratios for the analysis of Plasmodium falciparum in vitro susceptibility to antimalarial drugs.Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011 Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal In vitro evaluation of antiplasmodial activity of extracts of Acanthospermum hispidum DC (Asteraceae) and Ficus thonningii Blume (Moraceae), two plants used in traditional medicine in the Republic of Congo.Use of a colorimetric (DELI) test for the evaluation of chemoresistance of Plasmodium falciparum and Plasmodium vivax to commonly used anti-plasmodial drugs in the Brazilian Amazon.Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies Field-based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivity A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs.Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs In vitro antiplasmodial activity and cytotoxicity of extracts and fractions of Vitex madiensis, medicinal plant of Gabon.Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using a Bayesian approach.A new double-antibody sandwich ELISA targeting Plasmodium falciparum aldolase to evaluate anti-malarial drug sensitivity.Antiplasmodial activities of dyes against Plasmodium falciparum asexual and sexual stages: Contrasted uptakes of triarylmethanes Brilliant green, Green S (E142), and Patent Blue V (E131) by erythrocytes.World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility.Antiplasmodial activity of selected medicinal plants used to treat malaria in Ghana.Sentinel network for monitoring in vitro susceptibility of Plasmodium falciparum to antimalarial drugs in Colombia: a proof of concept.Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.Several human cyclin-dependent kinase inhibitors, structurally related to roscovitine, are new anti-malarial agents.Induction of high tolerance to artemisinin by sub-lethal administration: A new in vitro model of P. falciparum.Chloroquine exposure triggers distinct cellular responses in sensitive versus resistant Plasmodium falciparum parasites

P2860

Q28125917-03F20DFA-08E1-4063-8D34-42CB927C078B Q28534753-46824A04-6383-4611-8708-79E5BB3A40EB Q30619647-99F0C97A-5F2F-4B08-8DD9-193DCA411FEB Q33685005-F3C967ED-18B4-43F2-A973-A52DF01566D4 Q33817484-FB3F1C8D-10BD-4369-9952-9D1A0C5CE838 Q34082282-0E5B6A23-A6E1-4439-8E99-2BA05DAB6905 Q34478362-5E9071AE-37B8-40F4-8144-BF536069E820 Q34597550-C107BD24-259F-4F8B-8C25-2020897E5C0E Q34957514-82F99393-9363-496E-9808-9405A805DE10 Q35105899-457614B6-228C-4377-AF95-747DE4EE8782 Q35368698-7B1CEA1A-2805-4B1C-9C23-7F2EC7DAD775 Q35533577-11181EE6-0092-426F-9A09-F2FA829BFB15 Q35820389-5D8A53E3-F36E-4111-8C77-BF5E40DD50F5 Q35848309-0D5E538F-5F73-4B48-A041-3154BA9F4E9B Q35859975-BC1476E2-F9BA-429F-BE84-89CA76C1AA78 Q35947492-66553A88-529D-45B9-96AE-6471A53540EE Q36372815-10782623-6F3D-4BE3-AB3A-CA87CC6934B9 Q36449476-6692576D-8ED1-4E96-A027-EB80EC5D6878 Q36643101-8EBFD1E8-9A00-4AED-BE82-158A385D4D16 Q36711959-8A06A607-1CBB-412D-932C-5128BB438F5F Q36921820-48B815A1-7B01-4802-AB11-633E4701F676 Q37103018-2230EA51-E7CA-41EA-AE4B-5CEA8514E10A Q37153232-0527A5EA-A12F-4E4F-B5B8-2E61DA3EFA56 Q37240876-0B72AD88-1913-4720-AE48-2676CAFBD445 Q37263905-E78669CA-16C2-4658-9DB3-250B483610A7 Q37426615-EDB7DB36-F3BF-4B72-9C63-108788CF07E0 Q37436582-38695519-983F-4419-9840-E2F888022A5B Q37544298-4F6A7C73-412F-4EB6-BD63-A9EA8D29C577 Q38970753-54C18549-AA61-4827-96E4-2995FDB1E1EE Q39433031-E2B06A5E-57DF-41E3-8E0E-A4E75603D6D8 Q39489920-C3A1CE17-CDDA-425F-9300-70566A3678BF Q39534318-4FF8ECC6-DC35-42FF-93AD-D44EF58C024D Q40050625-1FA91D34-A1C9-4C15-BE7F-31088F40ED3F Q41410017-A26A3E3F-F337-4167-B3EA-6586E37E7F3A Q41915110-FA817261-D5B6-4D3A-8924-7F847CDAD8C2 Q41931788-E7841D8A-696A-41FB-A004-D48A27E2A263 Q42112205-9A0342C2-C4A9-4AC9-83C7-FA73A40A0244 Q47884524-51658650-1349-45EA-9DED-1B7E7EBD7AB7 Q48022305-E4A78602-C8C5-4FF3-B75C-6FAB9F27DD32 Q56358062-C12A95FC-D935-447E-866E-F5A40727E7DE

P2860

Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitor

http://www.wikidata.org/entity/Q35091549

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Assessment of the drug suscept ...... nt of the 50-percent inhibitor

@ast

Assessment of the drug suscept ...... nt of the 50-percent inhibitor

@en

type

label

Assessment of the drug suscept ...... nt of the 50-percent inhibitor

@ast

Assessment of the drug suscept ...... nt of the 50-percent inhibitor

@en

prefLabel

Assessment of the drug suscept ...... nt of the 50-percent inhibitor

@ast

Assessment of the drug suscept ...... nt of the 50-percent inhibitor

@en

P1433

Q35091549-FA964FCD-1F3F-480F-BD21-2F4D7D5D7A60

P1476

Q35091549-B79F8B68-895F-4C26-846C-54F768DF9015

P2093

Q35091549-088D5E32-41F0-405D-AC14-DF1942A466ED

Q35091549-8FFE243B-25E5-4E69-B130-AEBC9A96E990

Q35091549-BE1D6582-C8AD-4509-A47A-0850FA4F4400

P2860

Q35091549-16A29313-7E24-411A-B3F1-2C1022F991E7

Q35091549-1A500E6C-6140-4F73-87F4-C724255E3CCF

Q35091549-53C2F13B-AE66-4826-BEB6-CA38C49575D3

Q35091549-5BBA5AB7-AB5C-4744-8094-C99F9DB41A2C

Q35091549-5EA90AD9-2A8D-4988-ABE1-A0FB58CB0F10

Q35091549-7053A18D-42CA-4D42-9DA9-5D36D7800E75

Q35091549-7319D9E0-C404-425B-86A0-9DA4AF8A732B

Q35091549-74B99FC7-2863-45E2-A5FB-937FD2186633

Q35091549-907B736D-45B1-4771-A984-0A9F225D439E

Q35091549-96DB658B-FBBA-40E6-B7C9-E0C8B6EB4211

P304

Q35091549-C6932E9D-68E5-43BD-9904-13BEDCFBB356

P31

Q35091549-B9F33743-C56F-403E-979A-FCCD36973FA3

P356

Q35091549-AB04BCCC-17FD-47B2-90C3-62F891D95E4E

P407

Q35091549-F0033985-102D-412D-A187-A9CCC7166161

P433

Q35091549-EEA7D4D0-70EB-45AA-B222-423122667F97

P478

Q35091549-B6D59977-6E06-4737-BF4D-5CD7F1016BD6

P50

Q35091549-482D8971-87F3-45F4-9435-7C8FFBD49160

Q35091549-A8F5C4A4-C3CF-425B-B63E-01C712505431

P577

Q35091549-FE640992-E7D2-4FDC-BA1D-8AB3FD767270

P698

Q35091549-625CB207-AFCA-4715-8B4C-7716E80AEF71

P921

Q35091549-3E1B0FB8-4C80-45E6-9B07-39721F8D1A18

P932

Q35091549-A70C1686-0672-4185-BD17-BC39A5441BAC

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Assessment of the drug suscept ...... nt of the 50-percent inhibitor

@en

P2093

France Mentré

http://www.w3.org/2001/XMLSchema#string

Halima Kaddouri

http://www.w3.org/2001/XMLSchema#string

Serge Nakache

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

Biochemistry of Plasmodium (malarial parasites).

In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs.

Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaoundé, Cameroon.

Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing.

Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria.

Histidine-rich protein II: a novel approach to malaria drug sensitivity testing.

A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay.

Field evaluation of a novel colorimetric method--double-site enzyme-linked lactate dehydrogenase immunodetection assay--to determine drug susceptibilities of Plasmodium falciparum clinical isolates from northwestern Thailand.

P304

3343-3349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00367-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Jacques Le Bras

Sandrine Houzé

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17005815

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

1610081

http://www.w3.org/2001/XMLSchema#string